Cyclosporin A, an immunosuppressive agent, inhibits the expression and activity of PKM2 in breast cancer cell lines (MCF-7, MDA-MB-435, and MDA-MB-231) and causes tumor cell death by reducing cell viability (Jiang K. et al., 2012). This evidence concerns the gene PKM and breast carcinoma.